KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

AbCellera Biologics (ABCL) Interest & Investment Income (2022 - 2023)

Historic Interest & Investment Income for AbCellera Biologics (ABCL) over the last 2 years, with Q4 2023 value amounting to $11.0 million.

  • AbCellera Biologics' Interest & Investment Income rose 2950.41% to $11.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was $42.2 million, marking a year-over-year increase of 16232.23%. This contributed to the annual value of $38.5 million for FY2024, which is 893.32% down from last year.
  • Latest data reveals that AbCellera Biologics reported Interest & Investment Income of $11.0 million as of Q4 2023, which was up 2950.41% from $10.7 million recorded in Q3 2023.
  • AbCellera Biologics' 5-year Interest & Investment Income high stood at $11.0 million for Q4 2023, and its period low was $665000.0 during Q1 2022.